|
[1]
|
Swerdlow, S.H., Campo, E., Harris, N.L., Jaffe, E.S., Pileri, S.A., Stein, H., et al. (2008) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th Edition, World Health Organization, Lyon.
|
|
[2]
|
Chiorazzi, N., Rai, K.R. and Ferrarini, M. (2005) Chronic Lymphocytic Leukemia. The New England Journal of Medicine, 352, 804-815.
http://dx.doi.org/10.1056/NEJMra041720
|
|
[3]
|
Dighiero, G., Travade, P., Chevret, S., Fenaux, P., Chastang, C. and Binet, J.L. (1991) B-Cell Chronic Lymphocytic Leukemia: Present Status and Future Directions. French Cooperative Group on CLL. Blood, 78, 1901-1914.
|
|
[4]
|
Rawstron, A.C. (2009) Monoclonal B-Cell Lymphocytosis. ASH Education Book, 2009, 430-439.
http://dx.doi.org/10.1182/asheducation-2009.1.430
|
|
[5]
|
Rossi, D., Sozzi, E., Puma, A., De Paoli, L., Rasi, S., Spina, V., et al. (2009) The Prognosis of Clinical Monoclonal B Cell Lymphocytosis Differs from Prognosis of Rai 0 Chronic Lymphocytic Leukaemia and Is Recapitulated by Biological Risk Factors. British Journal of Haematology, 146, 64-75.
http://dx.doi.org/10.1111/j.1365-2141.2009.07711.x
|
|
[6]
|
Shanafelt, T.D., Kay, N.E., Rabe, K.G., Call, T.G., Zent, C.S., Maddocks, K., et al. (2009) Natural History of Individuals with Clinically Recognized Monoclonal B-Cell Lymphocytosis Compared with Patients with Rai 0 Chronic Lymphocytic Leukemia. Journal of Clinical Oncology, 27, 3959-3963.
http://dx.doi.org/10.1200/JCO.2008.21.2704
|
|
[7]
|
Zenz, T., Gribben, J.G., Hallek, M., Döhner, H., Keating, M.J. and Stilgenbauer, S. (2012) Risk Categories and Refractory CLL in the Era of Chemoimmunotherapy. Blood, 119, 4101-4107.
http://dx.doi.org/10.1182/blood-2011-11-312421
|
|
[8]
|
Zenz, T., Mertens, D., Küppers, R., Döhner, H. and Stilgenbauer, S. (2010) From Pathogenesis to Treatment of Chronic Lymphocytic Leukaemia. Nature Reviews Cancer, 10, 37-50.
http://dx.doi.org/10.1038/nrc2764
|
|
[9]
|
Skinner, M.K., Manikkam, M. and Guerrero-Bosagna, C. (2010) Epigenetic Transgenerational Actions of Environmental Factors in Disease Etiology. Trends in Endocrinology & Metabolism, 21, 214-222.
http://dx.doi.org/10.1016/j.tem.2009.12.007
|
|
[10]
|
Doherty, R., Farrelly, C.O. and Meade, K.G. (2014) Comparative Epigenetics: Relevance to the Regulation of Production and Health Traits in Cattle. Animal Genetics, 45, 3-14.
http://dx.doi.org/10.1111/age.12140
|
|
[11]
|
Bhat, A.A., Wani, H.A., Beigh, M.A., Bhat, S.A., Jeelani, S., Massood, A., et al. (2013) Epigenetic Promoter Methylation of Hmlh1 Gene in Human Gut Malignancies: A Comparative Study. Journal of Investigational Biochemistry, 2, 101-108.
http://dx.doi.org/10.5455/jib.20130409124009
|
|
[12]
|
Feinberg, A.P. and Tycko, B. (2004) The History of Cancer Epigenetics. Nature Reviews Cancer, 4, 143-153.
http://dx.doi.org/10.1038/nrc1279
|
|
[13]
|
Deakin, J.E., Domaschenz, R., Lim, P.S., Ezaz, T. and Rao, S. (2014) Comparative Epigenomics: An Emerging Field with Breakthrough Potential to Understand Evolution of Epigenetic Regulation. AIMS Genetics, 1, 34-54.
http://dx.doi.org/10.3934/genet.2014.1.34
|
|
[14]
|
Henrique, R., Luis, A. and Jerónimo, C. (2012) The Epigenetics of Renal Cell Tumors: From Biology to Biomarkers. Frontiers in Genetics, 3, 94.
http://dx.doi.org/10.3389/fgene.2012.00094
|
|
[15]
|
Shi, Y. (2007) Histone Lysine Demethylases: Emerging Roles in Development, Physiology and Disease. Nature Reviews Genetics, 8, 829-833.
http://dx.doi.org/10.1038/nrg2218
|
|
[16]
|
Kouzarides, T. (2007) Chromatin Modifications and Their Function. Cell, 128, 693-705.
http://dx.doi.org/10.1016/j.cell.2007.02.005
|
|
[17]
|
Fraga, M.F., Ballestar, E., Villar-Garea, A., Boix-Chornet, M., Espada, J., Schotta, G., et al. (2005) Loss of Acetylation at Lys16 and Trimethylation at Lys20 of Histone H4 Is a Common Hallmark of Human Cancer. Nature Genetics, 37, 391-400.
http://dx.doi.org/10.1038/ng1531
|
|
[18]
|
Nguyen, C.T., Weisenberger, D.J., Velicescu, M., Gonzales, F.A., Lin, J.C., Liang, G., et al. (2002) Histone H3-Lysine 9 Methylation Is Associated with Aberrant Gene Silencing in Cancer Cells and Is Rapidly Reversed by 5-Aza-2’- deoxycytidine. Cancer Research, 62, 6456-6461.
|
|
[19]
|
Langmead, B. and Salzberg, S.L. (2012) Fast Gapped-Read Alignment with Bowtie 2. Nature Methods, 9, 357-359.
http://dx.doi.org/10.1038/nmeth.1923
|
|
[20]
|
Wang, L., Feng, Z., Wang, X., Wang, X. and Zhang, X. (2010) DEGseq: An R Package for Identifying Differentially Expressed Genes from RNA-Seq Data. Bioinformatics, 26, 136-138.
http://dx.doi.org/10.1093/bioinformatics/btp612
|
|
[21]
|
Pruitt, K.D., Tatusova, T. and Maglott, D.R. (2007) NCBI Reference Sequences (RefSeq): A Curated Non-Redundant Sequence Database of Genomes, Transcripts and Proteins. Nucleic Acids Research, 35, D61-D65.
http://dx.doi.org/10.1093/nar/gkl842
|
|
[22]
|
Xu, H., Wei, C.-L., Lin, F. and Sung, W.-K. (2008) An HMM Approach to Genome-Wide Identification of Differential Histone Modification Sites from ChIP-Seq Data. Bioinformatics, 24, 2344-2349.
http://dx.doi.org/10.1093/bioinformatics/btn402
|